Solid Biosciences Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Solid Biosciences Inc. (SLDB) reported Increase (Decrease) in Prepaid Expense and Other Assets of $324.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- Solid Biosciences Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.28M, a 68.70% decline year-over-year.
- Solid Biosciences Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$954.00K.
- Solid Biosciences Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $7.65M.
- Solid Biosciences Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.72M, a 272.81% decline year-over-year.
- Solid Biosciences Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $7.99M, a 226.91% increase from fiscal 2024.
- Solid Biosciences Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.44M.
- Solid Biosciences Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$598.00K.
- Solid Biosciences Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$3.69M, a 139.96% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $324.00K 10-Q · filed 2026-08-06 | $7.97M derived: sum of 3 quarters · filed 2026-08-06 | $6.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$954.00K 10-Q · filed 2026-05-12 | $6.70M derived: sum of 2 quarters · filed 2026-05-12 | $4.98M derived: sum of 3 quarters · filed 2026-05-12 | $9.06M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $5.93M derived: sum of 2 quarters · filed 2026-03-19 | $10.02M derived: sum of 3 quarters · filed 2026-08-06 | $7.99M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | -$1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $2.37M derived: sum of 2 quarters · filed 2026-08-06 | $344.00K 10-Q · filed 2025-11-03 | $240.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.06M 10-Q · filed 2026-08-06 | $1.96M derived: sum of 3 quarters · filed 2026-08-06 | $2.95M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$2.02M 10-Q · filed 2026-05-12 | -$2.13M derived: sum of 2 quarters · filed 2026-05-12 | -$1.13M derived: sum of 3 quarters · filed 2026-05-12 | -$1.58M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $889.00K derived: sum of 2 quarters · filed 2026-03-19 | $447.00K derived: sum of 3 quarters · filed 2026-03-19 | $2.44M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $993.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $551.00K derived: sum of 2 quarters · filed 2025-11-03 | $2.55M 10-Q · filed 2025-11-03 | $3.08M derived: sum of 4 quarters · filed 2025-11-03 | ||||
| 2024-06-30 | -$442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.56M 10-Q · filed 2025-08-12 | $2.08M derived: sum of 3 quarters · filed 2025-08-12 | $395.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $2.00M 10-Q · filed 2025-05-15 | $1.34M 10-Q · filed 2024-05-15 | $2.52M derived: sum of 2 quarters · filed 2025-05-15 | $837.00K derived: sum of 3 quarters · filed 2025-05-15 | $2.66M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $526.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$1.16M derived: sum of 2 quarters · filed 2025-03-06 | $663.00K derived: sum of 3 quarters · filed 2025-03-06 | -$598.00K 10-K · filed 2025-03-06 | -$3.44M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $137.00K derived: sum of 2 quarters · filed 2024-11-06 | -$1.12M 10-Q · filed 2024-11-06 | -$3.31M 10-Q · filed 2023-11-08 | -$1.52M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $563.00K 10-Q · filed 2024-08-13 | -$962.00K 10-Q · filed 2023-08-14 | $169.00K derived: sum of 3 quarters · filed 2024-08-13 | -$2.55M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$1.26M 10-Q · filed 2024-05-15 | -$1.66M derived: sum of 2 quarters · filed 2024-05-15 | -$4.37M derived: sum of 3 quarters · filed 2024-05-15 | -$8.32M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$394.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$3.11M derived: sum of 2 quarters · filed 2024-03-13 | -$7.06M derived: sum of 3 quarters · filed 2024-03-13 | -$3.69M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | -$2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$6.67M derived: sum of 2 quarters · filed 2023-11-08 | -$3.30M 10-Q · filed 2023-11-08 | $4.31M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | -$3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$586.00K 10-Q · filed 2023-08-14 | $7.02M derived: sum of 3 quarters · filed 2024-03-13 | $9.28M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | $3.37M 10-Q · filed 2023-05-11 | $10.97M derived: sum of 2 quarters · filed 2024-03-13 | $13.23M derived: sum of 3 quarters · filed 2024-03-13 | $11.84M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $9.87M derived: sum of 2 quarters · filed 2024-03-13 | $8.48M derived: sum of 3 quarters · filed 2024-03-13 | $9.25M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $870.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.64M 10-Q · filed 2022-11-10 | $3.06M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2021-06-30 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$621.00K 10-Q · filed 2022-08-11 | $799.00K derived: sum of 3 quarters · filed 2023-03-23 | -$289.00K derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2021-03-31 | $769.00K 10-Q · filed 2022-04-27 | $2.19M derived: sum of 2 quarters · filed 2023-03-23 | $1.10M derived: sum of 3 quarters · filed 2023-03-23 | -$466.00K derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2020-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $332.00K derived: sum of 2 quarters · filed 2023-03-23 | -$1.24M derived: sum of 3 quarters · filed 2023-03-23 | -$30.00K 10-K · filed 2023-03-23 | ||||
| 2020-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$2.65M derived: sum of 2 quarters · filed 2021-11-03 | -$1.45M 10-Q · filed 2021-11-03 | -$7.04M derived: sum of 4 quarters · filed 2022-03-14 | ||||
| 2020-06-30 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$362.00K 10-Q · filed 2021-08-16 | -$5.95M derived: sum of 3 quarters · filed 2022-03-14 | -$9.15M derived: sum of 4 quarters · filed 2022-03-14 | ||||
| 2020-03-31 | $1.21M 10-Q · filed 2021-05-14 | -$4.39M derived: sum of 2 quarters · filed 2022-03-14 | -$7.58M derived: sum of 3 quarters · filed 2022-03-14 | -$3.99M derived: sum of 4 quarters · filed 2022-03-14 | ||||
| 2019-12-31 | -$5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$8.79M derived: sum of 2 quarters · filed 2022-03-14 | -$5.19M derived: sum of 3 quarters · filed 2022-03-14 | -$4.49M 10-K · filed 2022-03-14 | ||||
| 2019-09-30 | -$3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $399.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.11M 10-Q · filed 2020-11-05 | $4.26M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-06-30 | $3.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.30M 10-Q · filed 2020-08-06 | $7.46M derived: sum of 3 quarters · filed 2021-03-15 | $8.81M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-03-31 | $707.00K 10-Q · filed 2020-05-07 | $3.87M derived: sum of 2 quarters · filed 2021-03-15 | $5.21M derived: sum of 3 quarters · filed 2021-03-15 | $5.00M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2018-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $4.51M derived: sum of 2 quarters · filed 2021-03-15 | $4.29M derived: sum of 3 quarters · filed 2021-03-15 | $4.93M 10-K · filed 2021-03-15 | ||||
| 2018-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.13M derived: sum of 2 quarters · filed 2019-11-12 | $1.77M 10-Q · filed 2019-11-12 | $2.09M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | -$217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $424.00K 10-Q · filed 2019-08-14 | $741.00K derived: sum of 3 quarters · filed 2020-03-12 | $1.22M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $641.00K 10-Q · filed 2019-05-13 | $958.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.43M derived: sum of 3 quarters · filed 2020-03-12 | $10.00K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $791.00K derived: sum of 2 quarters · filed 2020-03-12 | -$631.00K derived: sum of 3 quarters · filed 2020-03-12 | -$815.00K 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | $474.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$948.00K derived: sum of 2 quarters · filed 2018-11-13 | -$1.13M 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | -$1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$1.61M 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | -$184.00K 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | $2.00M 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |